Jiujie Cui

3.2k total citations
71 papers, 2.3k citations indexed

About

Jiujie Cui is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jiujie Cui has authored 71 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 32 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Jiujie Cui's work include Pancreatic and Hepatic Oncology Research (22 papers), FOXO transcription factor regulation (11 papers) and MicroRNA in disease regulation (7 papers). Jiujie Cui is often cited by papers focused on Pancreatic and Hepatic Oncology Research (22 papers), FOXO transcription factor regulation (11 papers) and MicroRNA in disease regulation (7 papers). Jiujie Cui collaborates with scholars based in China, United States and Hong Kong. Jiujie Cui's co-authors include Keping Xie, Zhiliang Jia, Yong Gao, Dacheng Xie, Ming Quan, Daoyan Wei, Liwei Wang, Suyun Huang, Jiao Feng and Min Shi and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.

In The Last Decade

Jiujie Cui

69 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiujie Cui China 27 1.7k 857 811 282 218 71 2.3k
Yong Gao China 26 1.5k 0.9× 750 0.9× 495 0.6× 250 0.9× 211 1.0× 97 2.0k
Zebin Wang China 19 1.5k 0.9× 659 0.8× 692 0.9× 196 0.7× 182 0.8× 49 2.2k
Bisrat G. Debeb United States 28 1.3k 0.8× 810 0.9× 1.1k 1.4× 310 1.1× 186 0.9× 61 2.3k
Chuyong Lin China 33 2.0k 1.2× 1.3k 1.5× 630 0.8× 333 1.2× 303 1.4× 60 2.8k
Enping Xu China 25 1.4k 0.9× 1.0k 1.2× 606 0.7× 246 0.9× 241 1.1× 49 2.3k
Francesco Dituri Italy 23 1.4k 0.9× 692 0.8× 788 1.0× 272 1.0× 337 1.5× 62 2.5k
Yanru Qin China 30 1.9k 1.1× 1.1k 1.2× 689 0.8× 454 1.6× 279 1.3× 98 2.7k
Sebastian Oltean United Kingdom 25 2.0k 1.2× 753 0.9× 733 0.9× 454 1.6× 187 0.9× 50 2.8k
Altaf A. Dar United States 27 2.0k 1.2× 1.2k 1.5× 622 0.8× 239 0.8× 116 0.5× 51 2.5k
Mingxia Yan China 20 1.9k 1.1× 1.4k 1.7× 945 1.2× 180 0.6× 152 0.7× 37 2.7k

Countries citing papers authored by Jiujie Cui

Since Specialization
Citations

This map shows the geographic impact of Jiujie Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiujie Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiujie Cui more than expected).

Fields of papers citing papers by Jiujie Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiujie Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiujie Cui. The network helps show where Jiujie Cui may publish in the future.

Co-authorship network of co-authors of Jiujie Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Jiujie Cui. A scholar is included among the top collaborators of Jiujie Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiujie Cui. Jiujie Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Haiyan, Yang Sun, Jingyu Ma, et al.. (2025). CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment. Journal for ImmunoTherapy of Cancer. 13(1). e010029–e010029. 1 indexed citations
2.
Wang, Lei, Kuirong Jiang, Wenxin Li, et al.. (2025). 2215O HRS-4642 combined with gemcitabine and nab-paclitaxel in KRAS-G12D mutant advanced pancreatic cancer: A phase Ib/II study. Annals of Oncology. 36. S1146–S1146.
3.
Ge, Weiyu, Tiebo Mao, Xiaofei Zhang, et al.. (2022). Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer. Disease Markers. 2022. 1–22. 10 indexed citations
4.
Ge, Weiyu, Kexuan Wang, Tiebo Mao, et al.. (2022). Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma. Frontiers in Cell and Developmental Biology. 10. 942225–942225. 6 indexed citations
5.
6.
Zhang, Xiao, Xiaofei Zhang, Tiebo Mao, et al.. (2021). CSE1L, as a novel prognostic marker, promotes pancreatic cancer proliferation by regulating the AKT/mTOR signaling pathway. Journal of Cancer. 12(10). 2797–2806. 10 indexed citations
7.
Yan, Yi–Dan, Jiujie Cui, Jie Fu, et al.. (2021). A Network Comparison on Safety Profiling of Immune Checkpoint Inhibitors in Advanced Lung Cancer. Frontiers in Immunology. 12. 760737–760737. 19 indexed citations
8.
Feng, Jiao, Ting Han, Cuncun Yuan, et al.. (2020). Caveolin-2 is regulated by BRD4 and contributes to cell growth in pancreatic cancer. Cancer Cell International. 20(1). 22 indexed citations
9.
10.
Cui, Jiujie, Zhuqing Zhou, Haiyan Yang, et al.. (2019). MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis. Molecular Cancer Research. 17(6). 1316–1325. 101 indexed citations
11.
Guo, Kun, Jiujie Cui, Ming Quan, et al.. (2016). The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer. Clinical Cancer Research. 23(3). 687–696. 67 indexed citations
12.
Quan, Ming, Jiujie Cui, Tian Xia, et al.. (2015). Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling. Cancer Research. 75(22). 4778–4789. 44 indexed citations
13.
Li, Zhiwei, Zhiliang Jia, Yong Gao, et al.. (2014). Activation of Vitamin D Receptor Signaling Downregulates the Expression of Nuclear FOXM1 Protein and Suppresses Pancreatic Cancer Cell Stemness. Clinical Cancer Research. 21(4). 844–853. 49 indexed citations
14.
Cui, Jiujie, Min Shi, Dacheng Xie, et al.. (2014). FOXM1 Promotes the Warburg Effect and Pancreatic Cancer Progression via Transactivation of LDHA Expression. Clinical Cancer Research. 20(10). 2595–2606. 197 indexed citations
15.
Huang, Chen, Dacheng Xie, Jiujie Cui, et al.. (2014). FOXM1c Promotes Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis via Upregulation of Expression of the Urokinase Plasminogen Activator System. Clinical Cancer Research. 20(6). 1477–1488. 73 indexed citations
16.
Shi, Min, Jiujie Cui, Jiawei Du, et al.. (2014). A Novel KLF4/LDHA Signaling Pathway Regulates Aerobic Glycolysis in and Progression of Pancreatic Cancer. Clinical Cancer Research. 20(16). 4370–4380. 156 indexed citations
17.
Kong, Xiangyu, Lei Li, Zhaoshen Li, et al.. (2013). Dysregulated Expression of FOXM1 Isoforms Drives Progression of Pancreatic Cancer. Cancer Research. 73(13). 3987–3996. 86 indexed citations
18.
Li, Lei, Yiqi Du, Xiangyu Kong, et al.. (2013). Lamin B1 Is a Novel Therapeutic Target of Betulinic Acid in Pancreatic Cancer. Clinical Cancer Research. 19(17). 4651–4661. 85 indexed citations
19.
Li, Dawei, Ping Wei, Zhihai Peng, et al.. (2012). The Critical Role of Dysregulated FOXM1–PLAUR Signaling in Human Colon Cancer Progression and Metastasis. Clinical Cancer Research. 19(1). 62–72. 94 indexed citations
20.
Cui, Jiujie, Weihua Jiang, Shu‐Yi Wang, Liwei Wang, & Keping Xie. (2012). Role of Wnt/β-catenin Signaling in Drug Resistance of Pancreatic Cancer. Current Pharmaceutical Design. 18(17). 2464–2471. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong Gao Breakdown of academic impact, for papers by Zebin Wang Breakdown of academic impact, for papers by Bisrat G. Debeb Breakdown of academic impact, for papers by Chuyong Lin Breakdown of academic impact, for papers by Enping Xu Breakdown of academic impact, for papers by Francesco Dituri Breakdown of academic impact, for papers by Yanru Qin Breakdown of academic impact, for papers by Sebastian Oltean Breakdown of academic impact, for papers by Altaf A. Dar Breakdown of academic impact, for papers by Mingxia Yan
Rankless by CCL
2026